Table 2.
Regression analysis results for factors associated with anxiety and depression symptoms.
| HADS-Anxiety score | HADS-Depression score | |||
|---|---|---|---|---|
| Estimates (95 % confidence interval) |
Estimates (95 % confidence interval) |
|||
| Univariate analysis1 | Multivariate analysis2 | Univariate analysis1 | Multivariate analysis2 | |
| Age, year | −1.41 (−1.95, −0.88)*** | −0.10 (−0.14, −0.06)*** | −0.35 (−1.08, 0.38) | −0.04 (−0.07, −0.01)* |
| Sex3 | −0.03 (−0.05, −0.01)*** | −1.28 (−2.35, −0.22)* | −0.01 (−0.04, 0.01) | −0.29 (−1.21, 0.64) |
| Diabetes duration, year | −0.32 (−0.81, 0.16) | 0.03 (−0.02, 0.07) | 0.36 (−0.26, 0.99) | 0.03 (0.00, 0.07) |
| Automated insulin delivery feature4 | −0.01 (−0.03, 0.01) | −0.69 (−1.73, 0.34) | −0.01 (−0.04, 0.01) | −0.59 (−1.48, 0.31) |
| Number of severe hypoglycemia | 0.04 (−0.16, 0.24) | −0.01 (−0.10, 0.08) | 0.05 (−0.21, 0.30) | −0.01 (−0.08, 0.07) |
| Gold score5 | 0.08 (0.02, 0.14) | 0.52 (0.21, 0.82)** | 0.13 (0.05, 0.20)*** | 0.42 (0.15, 0.68)** |
| A2A asymptomatic hypoglycemia normalized belief score6 | 0.11 (0.03, 0.19)** | 0.16 (−0.08, 0.39) | 0.06 (−0.04, 0.17) | 0.10 (−0.11, 0.30) |
| A2A hypoglycemia concerns minimized belief score6 | −0.02 (−0.11, 0.07) | −0.34 (−0.57, −0.12)** | −0.10 (−0.22, 0.02) | −0.17 (−0.36, 0.03)† |
| A2A hyperglycemia avoidance prioritized belief score6 | 0.14 (0.07, 0.21)*** | 0.55 (0.29, 0.82)*** | 0.07 (−0.03, 0.17) | 0.22 (−0.01, 0.45)‡ |
| CGM time spent with >180 mg/dL, % | 0.65 (0.02, 1.23)* | 0.01 (−0.02, 0.04) | 0.95 (0.15, 1.75) | 0.01 (−0.02, 0.04) |
| CGM time spent with <70 mg/dL, % | −0.08 (−0.19, 0.02) | −0.18 (−0.38, 0.03) | −0.19 (−0.32, −0.06)** | −0.24 (−0.42, −0.06)** |
| CGM glucose coefficient of variation, % | −0.03 (−0.21, 0.14) | −0.03 (−0.14, 0.09) | −0.09 (−0.32, 0.13) | 0.01 (−0.09, 0.11) |
A2A, attitudes to awareness of hypoglycemia; CGM, continuous glucose monitor; HADS, hospital anxiety and depression scale.
1
Simple linear regression analysis.
2
Multiple linear repression analysis, adjusted for all other variables in table.
3
Female as reference.
4
Not using automated insulin delivery feature as reference.
5
Measured by Gold instrument (Ref. [23]).
6
Measured by A2A instrument (Ref. [24]).
*
P < 0.05.
**
P < 0.01.
***
P < 0.001.
‡
P = 0.061.
†
P = 0.090.